Improved hospital discharge and cost savings with esophageal cooling during left atrial ablation

Background: Left atrial ablation to obtain pulmonary vein isolation (PVI) for the treatment of atrial fibrillation (AF) is a technologically intensive procedure utilizing innovative and continually improving technology. Changes in the technology utilized for PVI can in turn lead to changes in procedure costs. Because of the proximity of the esophagus to the posterior wall of the left atrium, various technologies have been utilized to protect against thermal injury during ablation. The impact on hospital costs during PVI ablation from utilization of different technologies for esophageal protection during ablation has not previously been evaluated. Objective: To compare the costs of active esophageal cooling to luminal esophageal temperature (LET) monitoring during left atrial ablation. Methods: We performed a time-driven activity-based costing (TDABC) analysis to determine costs for PVI procedures. Published data and literature review were utilized to determine differences in procedure time and same-day discharge rates using different esophageal protection technologies and to determine the cost impacts of same-day discharge versus overnight hospitalization after PVI procedures. The total costs were then compared between cases using active esophageal cooling to those using LET monitoring. Results: The effect of implementing active esophageal cooling was associated with up to a 24.7% reduction in mean total procedure time, and an 18% increase in same-day discharge rate. TDABC analysis identified a $681 reduction in procedure costs associated with the use of active esophageal cooling after including the cost of the esophageal cooling device. Factoring in the 18% increase in same-day discharge resulted in an increased cost savings of $2,135 per procedure. Conclusions: The use of active esophageal cooling is associated with significant cost-savings when compared to traditional LET monitoring, even after accounting for the additional cost of the cooling device. These savings originate from a per-patient procedural time savings and a per-population improvement in same-day discharge rate.

[1]  J. Zagrodzky,et al.  Active esophageal cooling during radiofrequency ablation of the left atrium: data review and update , 2022, Expert review of medical devices.

[2]  M. Sohal,et al.  Effect of esophageal cooling on ablation lesion formation in the left atrium: Insights from Ablation Index data in the IMPACT trial and clinical outcomes , 2022, Journal of cardiovascular electrophysiology.

[3]  E. Antman,et al.  Atrial Fibrillation and Catheter Ablation. , 2022, The New England journal of medicine.

[4]  J. Zagrodzky,et al.  Esophageal cooling during ablation of persistent atrial fibrillation is associated with improved freedom from arrhythmia at one-year follow up , 2022, European Heart Journal.

[5]  S. Mickelsen,et al.  Proactive esophageal cooling protects against thermal insults during high-power short-duration radiofrequency cardiac ablation , 2022, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[6]  A. Natale,et al.  Composite Index Tagging for PVI in Paroxysmal AF: A Prospective, Multicenter Postapproval Study. , 2022, JACC. Clinical electrophysiology.

[7]  J. Zagrodzky,et al.  Arrhythmia recurrence reduction with an active esophageal cooling device during radiofrequency ablation , 2022, EP Europace.

[8]  J. Zagrodzky,et al.  ONE-YEAR OUTCOMES AFTER ACTIVE COOLING DURING LEFT ATRIAL RADIOFREQUENCY ABLATION , 2022, Journal of the American College of Cardiology.

[9]  M. Drummond,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. , 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  Eric L. Smith,et al.  Total Knee Arthroplasty Hospital Costs by Time-Driven Activity-Based Costing: Robotic vs Conventional , 2021, Arthroplasty today.

[11]  J. Zagrodzky,et al.  Impact of Active Esophageal Cooling on Fluoroscopy Usage During Left Atrial Ablation , 2021, The Journal of innovations in cardiac rhythm management.

[12]  N. Marrouche,et al.  Esophageal temperature during atrial fibrillation ablation poorly predicts esophageal injury: An observational study , 2021, Heart rhythm O2.

[13]  J. Nazari,et al.  Procedural time reduction associated with active esophageal cooling during pulmonary vein isolation , 2021, Journal of Interventional Cardiac Electrophysiology.

[14]  M. Kowalski,et al.  Economics and laboratory efficiency of atrial fibrillation ablation. , 2021, Current opinion in cardiology.

[15]  M. Sheppard,et al.  Preventing esophageal complications from atrial fibrillation ablation: A review , 2021, Heart rhythm O2.

[16]  R. Sandhu,et al.  Cost‐Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation , 2021, Journal of the American Heart Association.

[17]  V. Reddy,et al.  Barriers and financial impact of same‐day discharge after atrial fibrillation ablation , 2021, Pacing and clinical electrophysiology : PACE.

[18]  D. Lin,et al.  Active esophageal cooling for the prevention of thermal injury during atrial fibrillation ablation: a randomized controlled pilot study , 2021, Journal of Interventional Cardiac Electrophysiology.

[19]  J. Geller,et al.  Temperature Monitoring and Temperature-driven irrigated Radiofrequency Energy Titration do not prevent thermally-induced Esophageal Lesions in Pulmonary Vein Isolation A randomized study controlled by esophagoscopy before and after catheter ablation. , 2021, Heart rhythm.

[20]  M. Sohal,et al.  Randomized comparison of oesophageal protection with a temperature control device: results of the IMPACT study , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  G. Hindricks,et al.  Oesophageal Probe Evaluation in Radiofrequency Ablation of Atrial Fibrillation (OPERA): results from a prospective randomized trial. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  Prasad R Shankar,et al.  Time-Driven Activity-Based Costing in Radiology: An Overview. , 2020, Journal of the American College of Radiology : JACR.

[23]  A. Aizer,et al.  Quantitative analysis of ablation technique predicts arrhythmia recurrence following atrial fibrillation ablation. , 2019, American heart journal.

[24]  E. Heist,et al.  Economic impact of contact force sensing in catheter ablation for atrial fibrillation , 2019, Cardiovascular Electrophysiology.

[25]  Nohemi Sadule Rios,et al.  Implanting Loop Recorders in a Hospital Unit versus the Electrophysiology Laboratory: A Retrospective Chart Review , 2019, Nursing & Health Sciences Research Journal.

[26]  M. A. Mangi,et al.  Choosing Wisely Campaign – Innovations in Cardiovascular Science and The United States Healthcare System , 2018, Cureus.

[27]  F. Morady,et al.  Ablation of paroxysmal atrial fibrillation using a second‐generation cryoballoon catheter or contact‐force sensing radiofrequency ablation catheter: A comparison of costs and long‐term clinical outcomes , 2018, Journal of cardiovascular electrophysiology.

[28]  I. Kalsekar,et al.  Use of the THERMOCOOL SMARTTOUCH catheter for ablation of atrial fibrillation: the relationship between hospital procedure volume, re-admissions, and economic outcomes , 2018, Journal of medical economics.

[29]  E. Heist,et al.  Catheter Ablation for Cardiac Arrhythmias: Utilization and In-Hospital Complications, 2000 to 2013. , 2017, JACC. Clinical electrophysiology.

[30]  T. Potpara,et al.  Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians , 2017, Advances in Therapy.

[31]  J. Rizzo,et al.  Cost comparison of radiofrequency catheter ablation versus cryoablation for atrial fibrillation in hospitals using both technologies , 2016, Journal of medical economics.

[32]  Jan Petru,et al.  EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[33]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[34]  Aman Mahajan,et al.  Time-driven activity-based costing: a driver for provider engagement in costing activities and redesign initiatives. , 2014, Neurosurgical focus.

[35]  D. Singer,et al.  Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. , 2013, The American journal of cardiology.

[36]  R. Winkle,et al.  Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation , 2013, Journal of Interventional Cardiac Electrophysiology.

[37]  R. Kaplan,et al.  Time-driven activity-based costing. , 2003, Harvard business review.

[38]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[39]  Policy Approaches to Reduce What Commercial Insurers Pay for Hospitals’ and Physicians’ Services , 2022 .